Dedicated to serving patients with aortic disease, TriVascular is committed to providing optimal solutions for endovascular aortic repair (EVAR).

TriVascular’s initial product offerings are novel endovascular grafts that represent a significant advancement in EVAR. Building upon partnerships with thought leading clinicians worldwide, TriVascular’s products are designed to address unmet clinical needs and expand the pool of patients who are candidates for EVAR. Based in Santa Rosa, California, TriVascular offers highly talented, motivated individuals the opportunity to positively impact global healthcare.